20-F: Wearable Devices Reports Widened Losses Amid Revenue Growth

Wearable Devices Ltd. reported a 24% increase in 2025 revenue to $647,000, driven by B2C product sales, but net losses expanded to $8.1 million, alongside multiple capital raises and ongoing operational challenges.

Summary

• Revenue increased by approximately $125,000, or 24%, to $647,000 for the year ended December 31, 2025, primarily due to sales of the B2C Mudra Link.
• Net loss and total comprehensive loss for 2025 was approximately $8.1 million, an increase of 3% from $7.9 million in 2024.
• Operating loss for 2025 was $8.332 million, compared to $7.820 million in 2024.
• Cost of revenues increased by 64% to $594,000 in 2025, from $362,000 in 2024, mainly due to increased B2C sales and logistics costs.
• Impairment of product sales inventory totaled $201,000 in 2025, up from $75,000 in 2024, due to write-offs of obsolete inventory and increased provisions.
• Research and development expenses, net, increased by 18% to $3.504 million in 2025, driven by higher share-based compensation and labor costs.
• Sales and marketing expenses, net, decreased by 12% to $1.850 million in 2025, mainly due to reduced labor and consulting expenses, partially offset by increased share-based compensation.
• General and administrative expenses decreased slightly to $2.830 million in 2025, with lower professional services and insurance costs offset by increased share-based compensation and labor costs.
• The company raised approximately $20.5 million in net proceeds from several equity offerings and warrant inducement transactions in 2025.
• As of December 31, 2025, the company had an accumulated deficit of approximately $37.2 million.
• The Mudra Band for Apple Watch, a B2C product, commenced shipments in December 2023, with over 3,000 units delivered by March 11, 2026.
• The Mudra Link, a universal neural band, launched for pre-orders in September 2024 and began initial shipments in January 2025, with over 1,000 units delivered by March 11, 2026.
• The company launched Mudra Experience Studio in February 2026, a universal single codebase Neural Input Platform for XR and AI Developers, and formed ai6 Labs, a closed-loop AI ecosystem.
• The company received approval for an IIA grant of approximately $750,000 in December 2025 to support a clinical pilot program for the Mudra Link in rehabilitation applications.
• Multiple reverse share splits were effected: 1-for-20 on October 10, 2024, 1-for-4 on March 17, 2025, and 1-for-3 on March 11, 2026, to maintain Nasdaq compliance.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed report. While revenue growth and strategic product launches are positive, the widening net losses, increased inventory impairment, and continued reliance on capital raises for operations indicate significant financial challenges and risks for a growth-stage company.

Positives

• Revenue increased by 24% to $647,000 in 2025, primarily driven by B2C Mudra Link sales, indicating growing market acceptance for new products.
• Successful capital raises in 2025 generated approximately $20.5 million in net proceeds, strengthening liquidity.
• Launched new products and platforms, including the B2B Mudra Development Kit (January 2024), Spatial Depth control functionality (January 2024), Mudra Link (September 2024 pre-orders, January 2025 shipments), Mudra Experience Studio (February 2026), and ai6 Labs (February 2026).
• Received an IIA grant of approximately $750,000 in December 2025 for a clinical pilot program evaluating Mudra Link in rehabilitation, expanding into digital health.
• Maintained compliance with Nasdaq listing requirements after addressing minimum stockholders' equity and minimum bid price issues through capital raises and reverse stock splits.
• Established distribution arrangements in Japan (Media Exceed Co., Ltd. in August 2025) and South Korea (Sky Commerce Co., Ltd. in October 2025), expanding global reach.
• The Mudra Band for Apple Watch was included in the Best of CES 2024 products list by SlashGear, and Mudra Link won the CES 2025 Honoree Award in XR Technologies & Accessories, indicating industry recognition.

Negatives

• Net loss and total comprehensive loss increased by 3% to $8.1 million in 2025, from $7.9 million in 2024, indicating continued unprofitability.
• Operating loss increased to $8.332 million in 2025 from $7.820 million in 2024.
• Cost of revenues increased significantly by 64% to $594,000 in 2025, outpacing revenue growth.
• Impairment of product sales inventory increased to $201,000 in 2025, including $107,000 for obsolete inventory, suggesting challenges in inventory management or product demand.
• The company has suffered recurring losses and negative cash flows from operations since inception, with an accumulated deficit of $37.2 million as of December 31, 2025.
• Dependence on a limited number of suppliers, contract manufacturers, and logistics providers, with each product manufactured by a single contract manufacturer, poses significant supply chain risks.
• The period from initial B2B customer contact to signing a licensing agreement is estimated to be long (three-to-five years), and no licensing agreements have been signed as of March 11, 2026.
• Significant dilution to shareholders occurred due to multiple equity financings and warrant exercises, with Armistice Capital, LLC's beneficial ownership increasing to 50.51% as of March 11, 2026.
• The company's financial statements for 2023 and 2024 contained an explanatory paragraph regarding substantial doubt about its ability to continue as a going concern, which could recur in the future.

Risks

• Limited operating history and no assurance of achieving sufficient revenue or profitability.
• No assurance that wrist Surface Nerve Conductance (SNC) will become the dominant input method in wearable computing and consumer electronics.
• Inability to successfully develop and timely introduce new products or enhance existing ones.
• Quality problems with current and future products could lead to adverse publicity, recalls, litigation, and warranty claims.
• Long development cycles for B2B license agreements (3-5 years) and risk of cancellation or unsuccessful implementation.
• Reliance on a limited number of suppliers, contract manufacturers, and logistics providers, increasing supply chain vulnerability.
• Actual or perceived failure to comply with legal obligations regarding personal information and customer data (e.g., CCPA, GDPR) could harm the business.
• Forecasts of market growth for wearable computing devices may prove inaccurate, and the company's business may not grow at similar rates.
• The market for wearable computing devices is still in early stages, and slow or insufficient growth could harm the business.
• Intense competition from specialized consumer electronics companies and large broad-based technology companies.
• Economic downturns or uncertainty may adversely affect consumer discretionary spending and demand for products.
• Changes in laws and regulations related to the internet or internet infrastructure may diminish demand for services.
• Vulnerability to catastrophic events (earthquakes, fires, pandemics, power outages, terrorism) and manmade problems.
• Potential need to raise additional capital, which may not be available on acceptable terms and could result in further shareholder dilution.
• Operating results may fluctuate significantly due to various factors outside of the company's control.
• Geopolitical instability in Israel, including ongoing conflicts, may affect operations, limit ability to produce/sell products, or raise funds.
• Limitations from Israeli government grants, including royalty obligations and restrictions on manufacturing and technology transfer outside of Israel.
• Inability to adequately protect or enforce intellectual property rights globally, leading to costly efforts or infringement claims.
• Use of open-source software could negatively affect product sales and lead to litigation.
• Potential for claims challenging the inventorship of intellectual property.
• Changes in patent policy and rules could increase costs and uncertainties in patent prosecution and enforcement.
• Difficulty enforcing U.S. court judgments against the company or its officers/directors in Israel.
• Provisions of Israeli law and amended articles of association may delay or prevent mergers or acquisitions.
• Significant costs incurred as a public company, diverting management attention.
• Risks associated with doing business globally, including exchange controls, taxation changes, and political instability.
• Operating margins may decline due to increasing product costs, labor costs, and inflationary pressures.
• Market price volatility of Ordinary Shares and Warrants, potentially leading to loss of investment.
• Risk of securities litigation, which is expensive and diverts management attention.
• Failure to maintain effective internal control over financial reporting could materially adversely affect the business and investor confidence.
• Exclusive forum provision in articles of association may limit shareholders' ability to choose judicial forum for Securities Act claims.
• Potential liability claims for contract breaches, with inadequate insurance coverage.

Future Outlook

The company believes its existing cash, including proceeds from recent offerings, will be sufficient to support working capital and capital expenditure requirements through the end of 2027. Future capital requirements depend on R&D progress, manufacturing costs, revenue generation, intellectual property protection, and marketing efforts. The company expects revenue growth rates to slow in future periods due to increasing competition and market maturation. It plans to continue investing significantly in R&D and sales and marketing, and expects expenses to increase substantially in the near term. The company intends to achieve a leading position in neural input technology, expand operations to digital and wearable computers, introduce new features and use-cases, integrate Mudra technology into existing devices, further penetrate Industry 4.0, wellness, digital health, and sports analytics markets, and expand brand awareness and global distribution. Data monetization from gesture databases is also a future opportunity.

Management Comments

• "We are a growth company developing a non-invasive neural input interface in the form of a wearable wristband for controlling digital devices using subtle touchless finger movements."
• "We have completed the transition phase from research and development to commercialization of our technology into B2B and B2C products."
• "Our vision is to create a world in which the users hand becomes a universal input device to touchlessly interacting with technology. We believe that our technology is setting the standard input interface for the Metaverse."
• "We believe that neural-based interfaces will become as ubiquitous to interact with wearable computing and digital devices in the near future as the touchscreen is a universal input method for smartphones."
• "Our management believes that its cash will be sufficient for at least one year from the date of the approval of these financial statements."
• "We intend to maintain this number of employees and expenses during 2026, mainly to support our business development activities, the continuous research and development activity of our Mudra technology, and to manufacture the Mudra Band."

Industry Context

StockSavvy.ai notes that Wearable Devices Ltd. operates in the rapidly evolving Human-Computer Interface (HCI) and neurotech markets, which are experiencing significant growth driven by wearable computing devices, AR/VR headsets, and AI-powered applications. The company's focus on Surface Nerve Conductance (SNC) technology positions it within the emerging neural interface segment, aiming to provide a more natural and intuitive input method than traditional touchscreens or handheld controllers. The market is highly competitive, with major players like Apple (e.g., Apple Watch Ultra2 Double Tap), Meta (e.g., Meta Ray-Ban Display Glasses with Neural Band), Google, Microsoft, and specialized firms like DoublePoint and Pison. The company's 'push-pull' strategy, engaging both B2B manufacturers and B2C consumers, is a recognized approach to build market demand and validate technology in nascent markets. The expansion into digital health, Industry 4.0, and sport analytics aligns with broader industry trends of applying wearable sensor technology to diverse verticals beyond consumer entertainment.

Comparison to Industry Standards

• Wearable Devices' Mudra Band for Apple Watch and Mudra Link compete with established and emerging input methods. Apple's Watch Ultra2 Double Tap, based on IMU and PPG sensors, offers a similar touchless interaction but relies on different bio-signals compared to Mudra's EMG-based SNC sensors. Mudra's technology aims for more subtle and diverse gesture recognition.
• Meta Platforms Inc.'s Meta Ray-Ban Display Glasses with its Neural Band, launched in September 2025, represent a direct competitor to Mudra Link in the smart glasses segment, also utilizing neural wristband control with thumb micro-gestures.
• The company's B2B strategy targets integration into devices from major consumer electronics companies like Apple, Meta, Google, HTC, Samsung, Sony, Xreal, Viture, Rokid, RayNeo, and TCL, aiming to become a standard input interface, similar to how touchscreens became ubiquitous for smartphones.
• In the broader input device market, the company competes with traditional peripheral manufacturers such as Logitech International S.A. and Razer Inc., as well as voice assistant providers like Amazon.com, Inc. and Microsoft, and gesture detection camera solutions.
• Compared to invasive brain-computer interfaces like Neuralink's implants or Synchron's Stentrode, Mudra's non-invasive wearable approach targets mass consumer market adoption for gesture-based pointing functionality, while the invasive solutions remain primarily focused on medical applications.
• The company's collaboration with Rokid, expected for commercial rollout in Q2 2026, aims to integrate Mudra Link with Rokid's AR glasses, potentially offering a lighter form factor and extended battery life by offloading gesture recognition hardware, a competitive advantage against AR glasses with integrated cameras.

Management Changes

Corporate Governance

Legal Proceedings

• The company was not subject to any material legal proceedings that have had a material adverse effect on its financial position during the period covered by the financial statements.

Related Party Transactions

• Employment agreements with executive officers contain customary provisions regarding noncompetition, confidentiality, and assignment of inventions, with indemnification up to a certain amount.
• Executive officers are eligible for annual bonuses based on objectives and targets set by the CEO and approved by the board.
• New compensation terms for officers were approved by the board on March 6, 2022, and by shareholders on March 14, 2022.
• Shareholders approved an amended and restated compensation policy on September 26, 2024, and further amendments on October 24, 2025, and February 19, 2026.
• Options and Restricted Share Units (RSUs) have been granted to officers and certain directors under the 2015 Share Option Plan and 2024 Global Equity Incentive Plan.
• The company entered into a three-year consulting agreement with Pure Capital Ltd. on July 4, 2022, for investor relations and strategic services, with a monthly base fee of $35,000 (potentially increasing to $70,000). This agreement was terminated during Q4 2025.
• The company's co-founders (Asher Dahan, Guy Wagner, Leeor Langer) temporarily reduced their salaries in November 2024, which were partially reinstated in February 2025 and fully reinstated in September 2025.

Stakeholder Impact

• **Shareholders**: Experienced significant dilution from multiple equity offerings and warrant exercises, with Armistice Capital, LLC's beneficial ownership increasing to over 50%. The continued net losses and accumulated deficit pose risks to investment value, despite revenue growth. Reverse stock splits may negatively impact investor perception.
• **Employees**: Compensation includes salary, benefits, and equity-based awards (options, RSUs). Geopolitical instability in Israel could lead to military reserve duty call-ups, potentially disrupting operations. A one-time discretionary bonus was approved for certain office holders for their contribution to fundraising.
• **Customers (B2B & B2C)**: Benefit from new product launches (Mudra Link, Mudra Experience Studio) and enhanced features (Spatial Depth control). B2B customers face long development cycles (3-5 years) for licensing agreements, with no agreements signed yet. Quality problems or defects could harm customer satisfaction and brand reputation.
• **Suppliers & Contract Manufacturers**: The company relies on a limited number of suppliers and single contract manufacturers, creating supply chain risks that could impact product delivery and costs.
• **Creditors**: The company's recurring losses and going concern opinion in prior years indicate financial risk, though recent capital raises have improved liquidity. Contingent liabilities related to IIA grants and IMEI royalties exist.

Next Steps

• Continue to develop and introduce new products and features to expand the versatility and performance of the existing platform.
• Invest in building a diverse user-gesture data bank to develop additional new gestures.
• Further utilize Mudra technology and SNC sensors in multiple monitoring use-cases for digital health, sport analytics, and Industry 4.0 solutions.
• Leverage strong relationships with consumer electronics companies and brands to sign software and hardware licenses and royalty contracts.
• Increase focus on building relationships with corporations in Industry 4.0, wellness and digital health, and sports analytics.
• Increase marketing efforts to expand global brand awareness and drive sales, including through select retailers and strategic partnerships.
• Monetize data derived from gestures, daily behavior patterns, and metrics once a sufficiently large database is established.
• Commercial rollout of Mudra Link compatibility with Rokid AR glasses expected in the second quarter of 2026.
• Continue to pursue non-dilutive grants from the IIA and other organizations in Israel.

Key Dates

Recommendation

Wearable Devices Ltd. presents a high-risk, high-reward profile. While the company demonstrates promising technological innovation with new product launches (Mudra Link, Mudra Experience Studio) and strategic partnerships (Rokid), indicating potential for future growth in the nascent neural input and XR markets, its financial performance remains challenging. The significant increase in net losses and inventory impairment, coupled with recurring negative cash flows and an accumulated deficit, highlight the substantial operational and financial hurdles. The multiple reverse stock splits and heavy reliance on dilutive capital raises, particularly from a single institutional investor, introduce considerable shareholder risk. However, the company's strengthened liquidity from recent financings and its continued investment in R&D and market expansion suggest a commitment to commercialization. For a seasoned investor, the current stage warrants a 'hold' position, acknowledging the speculative nature and significant risks, but also the potential for long-term upside if the company successfully navigates its commercialization phase and secures B2B licensing agreements.

Keywords

Neural Input Interface, Wearable Technology, Gesture Control, Mudra Band, Mudra Link, Apple Watch Accessory, XR Technologies, AI Development, Brain-Computer Interface, Consumer Electronics, Digital Health, Industry 4.0, SNC Sensor, Israel Innovation Authority, Nasdaq Capital Market, SEC Filing, Form 20-F